Elevation Oncology Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	985.02	2,144	703.03
Cash & Short-Term Investments	985.02	2,144	703.03
Cash Growth	-54.06%	205.00%	-
Accounts Receivable	1,412	1,130	3,495
Other Receivables	15.18	12.5	0.96
Receivables	1,437	1,142	3,496
Inventory	4,905	1,457	1,368
Prepaid Expenses	20.79	12.54	40.73
Other Current Assets	6.92	2.1	57.12
Total Current Assets	7,354	4,758	5,665
Property, Plant & Equipment	18,272	14,506	12,015
Long-Term Investments	-	-	23.66
Other Intangible Assets	159.08	66.4	2.55
Other Long-Term Assets	192.57	205.77	88.49
Total Assets	25,978	19,536	17,795
Accounts Payable	1,641	596.65	2,973
Accrued Expenses	555.41	566.03	360.46
Short-Term Debt	2,222	1,852	400
Current Portion of Long-Term Debt	692.23	718.04	1,536
Current Portion of Leases	115.39	134.5	83.42
Current Income Taxes Payable	13.69	-	-
Current Unearned Revenue	8.17	-	19.8
Other Current Liabilities	8,228	4,770	1,922
Total Current Liabilities	13,476	8,637	7,295
Long-Term Debt	6,610	3,712	2,930
Long-Term Leases	131.25	128.43	64.36
Other Long-Term Liabilities	-	4.79	146.52
Total Liabilities	20,217	12,483	10,559
Common Stock	1,913	1,889	2,279
Additional Paid-In Capital	2,565	1,913	1,913
Retained Earnings	-2,647	3,422	3,043
Comprehensive Income & Other	-5,775	-5,850	-
Total Common Equity	-3,944	1,375	7,236
Shareholders' Equity	5,761	7,053	7,236
Total Liabilities & Equity	25,978	19,536	17,795
Total Debt	9,771	6,545	5,014
Net Cash (Debt)	-8,786	-4,401	-4,311
Net Cash Per Share	-23196.51	-10685.82	-10976.55
Filing Date Shares Outstanding	0.38	0.38	0.39
Total Common Shares Outstanding	0.38	0.38	0.39
Working Capital	-6,122	-3,879	-1,630
Book Value Per Share	-10306.62	3637.43	18422.37
Tangible Book Value	-4,103	1,308	7,233
Tangible Book Value Per Share	-10722.36	3461.71	18415.88
Land	744.74	744.74	744.74
Buildings	7,175	6,173	6,145
Machinery	13,860	8,007	7,388
Construction In Progress	457.5	2,397	21.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.